insights_auto
Why is GH down 4,21%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
145,32 $
arrow_downward
-4,21%(-6,38) 1D
16 նոյ, 11:20:57 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
149,56 $
High
149,60 $
Low
143,75 $
Mkt. cap
19,66 մլրդ
Avg. vol.
2,11 մլն
Volume
576,61 հզր
52-wk high
191,05 $
52-wk low
74,55 $
EPS
-3,68 $
Beta
1,67
Shares outstanding
135,29 մլն
No. of employees
2 հզր
Open
149,56 $
High
149,60 $
Low
143,75 $
Mkt. cap
19,66 մլրդ
Avg. vol.
2,11 մլն
Volume
576,61 հզր
52-wk high
191,05 $
52-wk low
74,55 $
EPS
-3,68 $
Beta
1,67
Shares outstanding
135,29 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
TradingView
·
12 ժամ առաջ
Reflecting on testing & diagnostics services stocks’ Q3 earnings: Guardant Health
Investing.com Nigeria
·
14 ժամ առաջ
Form 144 Guardant Health For: 15 November By Investing.com
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com